Calculates treatment threshold for diabetic macular oedema using central macular thickness (CMT >300-320 μm), BCVA, and anti-VEGF injection interval optimization using treat-and-extend protocol.
Calculates treatment threshold for diabetic macular oedema using central macular thickness (CMT >300-320 μm), BCVA, and anti-VEGF injection interval optimization using treat-and-extend protocol
Each component has a specific meaning:
Note: Interpret the dme cmt threshold result against the thresholds and context described above.
Enter the central macular thickness, BCVA, anti-VEGF injection interval optimization for the scenario you are assessing. Calculates treatment threshold for diabetic macular oedema using central macular thickness (CMT >300-320 μm), BCVA, and anti-VEGF injection interval optimization using treat-and-extend protocol. Use the dme cmt threshold result to inform your calculation.